Takeda - Better Health, Brighter Future

Better Health, Brighter Future

Takeda Completes Acquisition of Shire

Becoming a Global, Values-based, R&D-driven Biopharmaceutical Leader

LEARN MORE

Welcome to the global
corporate site for Takeda.

If you are looking for specific information,
please visit our country/region website.

SELECT A COUNTRY OR REGION SITE

Andy Plump on pushing the boundaries of science within the “new” Takeda R&D community

Ramona Sequeira, President of Takeda's U.S. Business Unit, on the many opportunities that lie ahead for the “new” Takeda

RECENT NEWS STOCK PRICE

Mar 09, 2019 Mar 09, 2019 Vedolizumab (Entyvio^®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira^®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis

Please wait...

Topics

Leaders in Global Health Interview Series

Our strength comes from within

Quarterly Announcements

Research & Development

Information

Takeda to Announce News Release of Shire's Full Year 2018 Results (4:30 pm JST on February 15th, 2019)

Financial Results Announcement (3:00 pm JST on February 1st, 2019)

Takeda Rings the Opening Bell at the New York Stock Exchange

Offer for Shire plc

Copyright 1995-2019 Takeda Pharmaceutical Company Limited. All rights reserved.